Working groups
Dr Annie McDougall completed her PhD in 2012, investigating molecular factors involved in fetal lung development. She has over seven years' experience as a post-doctoral biomedical scientist working at Monash University and the Ritchie Centre.
Annie’s research was focused on investigating the cellular and molecular factors involved normal lung development and neonatal lung and cerebellar injury. Her research utilised various models, such as primary cell cultures, knock-out mice and animal models of adverse perinatal conditions, including IUGR and ventilator-induced lung injury.
In 2019 Annie undertook a Masters of Public Health, and has made the career transition from the bench to applied public health research.
Her research interests include global health, improving outcomes for women and babies, maternal medicine development, guideline development, preterm birth and maternal mental health.
Annie is an active member of the perinatal research community. From 2014 – 2018, Annie co-chaired the Perinatal Society of Australia and New Zealand Early Career Researchers committee.
In addition, she is a community champion volunteer with Perinatal Anxiety and Depression Australia (PANDA) and has previously volunteered with the United Nations Development Programme, researching and preparing UNDP reports on the effects of tobacco control on the Sustainable Development Goals in LMICs.
PLOS Global Public Health
Joshua F. Ginnane, Connor Allen, Katherine E. Eddy, Sarah Cheang, Renae Nguyen, Nick Scott, Joshua P. Vogel, Annie R.A. McDougall, Connor Allen, Katherine E. Eddy
PLOS Global Public Health
Joshua F. Ginnane, Connor Allen, Katherine E. Eddy, Sarah Cheang, Renae Nguyen, Nick Scott, Joshua P. Vogel, Annie R.A. McDougall, Connor Allen, Katherine E. Eddy
BJOG An International Journal of Obstetrics & Gynaecology
Đinh Thanh Thúy, Sho Katsuragawa, Annie R.A. McDougall, Phi‐Yen Nguyen, Joshua P. Vogel, Maureen Makama, Đinh Thanh Thúy, Sho Katsuragawa, Annie R.A. McDougall, Phi‐Yen Nguyen
We're working to support the development of innovative medical products for pre-eclampsia.
Globally, approximately 287,000 women die every year from pregnancy-related conditions and complications, with most of these deaths occurring in low- and middle-income countries (LMICs). Although investment in global maternal health has increased in the past 30 years, research and development (R&D) of new products has been a neglected area.
This project will help people design and develop effective and affordable tools that more accurately predict pre-eclampsia in pregnant people.
The market for ultrasound devices is rapidly expanding, particularly as technological advances allow for smaller, cheaper, and more portable devices to be developed.
Burnet Institute and Concept Foundation have partnered to develop a new Target Product Profile (TPP) for maternal microbiome interventions, aiming to improve undernutrition and related maternal, fetal and neonatal outcomes.
We supported updates to the World Health Organization’s recommendations on the use of certain medications to improve preterm birth outcomes.